Literature DB >> 19364285

Persistence of high-capacity adenoviral vectors as replication-defective monomeric genomes in vitro and in murine liver.

Lorenz Jager1, Anja Ehrhardt.   

Abstract

Liver-based gene therapy approaches demonstrated that high-capacity adenoviral vectors (HC-AdVs) can persist life-long in mice and for 2 years or longer in rats, dogs, and nonhuman primates. However, the molecular status of episomal HC-AdV DNA molecules and the mechanism of vector genome maintenance have not been analyzed. HC-AdV lacks all viral coding sequences including early gene region 4 (E4), which prevents concatemerization in wild-type adenovirus. Therefore, we addressed whether concatemerization or circularization of HC-AdV DNA occurs in transduced cells. We employed pulsed-field gel electrophoresis and a sensitive concatemer/circle-specific polymerase chain reaction (PCR). To test for replication as a potential mechanism for maintenance, we developed a methylase/restriction endonuclease-based system using methylation-marked HC-AdV. We found that unlike DeltaE4 mutant virus, only monomers of HC-AdV genomes were observable in vitro. Using our methylase/restriction endonuclease-based system, no replication of HC-AdV was sensed in various cell lines. However, concatemer formation of HC-AdV could be induced after coinfection with an E4-deleted helper virus, indicating that linkage of genomes may be supported by replication. To examine HC-AdV DNA molecules in vivo, C57BL/6 mice were injected and vector DNA in liver was analyzed. In concordance with our in vitro results, exclusively linear monomers were detected. To sense the replication status of HC-AdV genomes, we established a sensitive real-time PCR. Our results indicated that the input transduced DNA genomes were the persistent molecules in murine liver. In summary, we demonstrated that HC-AdV genomes persist predominantly as replication-defective monomeric genomes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19364285     DOI: 10.1089/hum.2009.020

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  18 in total

Review 1.  Innate immunity to adenovirus: lessons from mice.

Authors:  Svetlana Atasheva; Jia Yao; Dmitry M Shayakhmetov
Journal:  FEBS Lett       Date:  2019-12-08       Impact factor: 4.124

Review 2.  Viral vectors for gene delivery to the central nervous system.

Authors:  Thomas B Lentz; Steven J Gray; R Jude Samulski
Journal:  Neurobiol Dis       Date:  2011-10-07       Impact factor: 5.996

3.  Assembly of helper-dependent adenovirus DNA into chromatin promotes efficient gene expression.

Authors:  P Joel Ross; Michael A Kennedy; Carin Christou; Milagros Risco Quiroz; Kathy L Poulin; Robin J Parks
Journal:  J Virol       Date:  2011-02-09       Impact factor: 5.103

Review 4.  Gene therapy with helper-dependent adenoviral vectors: lessons from studies in large animal models.

Authors:  Nicola Brunetti-Pierri; Philip Ng
Journal:  Virus Genes       Date:  2017-06-07       Impact factor: 2.332

5.  Hyperactive sleeping beauty transposase enables persistent phenotypic correction in mice and a canine model for hemophilia B.

Authors:  Martin A Hausl; Wenli Zhang; Nadine Müther; Christina Rauschhuber; Helen G Franck; Elizabeth P Merricks; Timothy C Nichols; Mark A Kay; Anja Ehrhardt
Journal:  Mol Ther       Date:  2010-08-17       Impact factor: 11.454

Review 6.  Recent gene therapy advancements for neurological diseases.

Authors:  Sahana Nagabhushan Kalburgi; Nadia N Khan; Steven J Gray
Journal:  Discov Med       Date:  2013-02       Impact factor: 2.970

Review 7.  Delivery approaches for CRISPR/Cas9 therapeutics in vivo: advances and challenges.

Authors:  D C Luther; Y W Lee; H Nagaraj; F Scaletti; V M Rotello
Journal:  Expert Opin Drug Deliv       Date:  2018-09-12       Impact factor: 6.648

8.  A Novel Adenoviral Hybrid-vector System Carrying a Plasmid Replicon for Safe and Efficient Cell and Gene Therapeutic Applications.

Authors:  Richard Voigtlander; Rudolf Haase; Martin Mück-Hausl; Wenli Zhang; Philip Boehme; Hans-Joachim Lipps; Eric Schulz; Armin Baiker; Anja Ehrhardt
Journal:  Mol Ther Nucleic Acids       Date:  2013-04-02       Impact factor: 10.183

9.  Gene therapy with helper-dependent adenoviral vectors: current advances and future perspectives.

Authors:  Francesco Vetrini; Philip Ng
Journal:  Viruses       Date:  2010-09-03       Impact factor: 5.818

10.  Viral hybrid vectors for somatic integration - are they the better solution?

Authors:  Nadine Müther; Nadja Noske; Anja Ehrhardt
Journal:  Viruses       Date:  2009-12-15       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.